A Pre-Clinical Large Animal Model of Sustained Liver Injury and Regeneration Stimulus

Kenta Inomata, Kazuki Tajima, Hiroshi Yagi, Hisanobu Higashi, Hirofumi Shimoda, Kentaro Matsubara, Taizo Hibi, Yuta Abe, Hanako Tsujikawa, Minoru Kitago, Masahiro Shinoda, Hideaki Obara, Osamu Itano, Alejandro Soto-Gutierrez, Yuukou Kitagawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A feasible large animal model to evaluate regenerative medicine techniques is vital for developing clinical applications. One such appropriate model could be to use retrorsine (RS) together with partial hepatectomy (PH). Here, we have developed the first porcine model using RS and PH. RS or saline control was administered intraperitoneally to Göttingen miniature pigs twice, two weeks apart. Four weeks after the second dose, animals underwent PH. Initially, we tested different doses of RS and resection of different amounts of liver, and selected 50 mg/kg RS with 60% hepatectomy as our model for further testing. Treated animals were sacrificed 3, 10, 17 or 28 days after PH. Blood samples and resected liver were collected. Serum and liver RS content was determined by Liquid Chromatograph-tandem Mass Spectrometer. Blood analyses demonstrated liver dysfunction after PH. Liver regeneration was significantly inhibited 10 and 17 days after PH in RS-treated animals, to the extent of 20%. Histological examination indicated hepatic injury and regenerative responses after PH. Immunohistochemical staining demonstrated accumulation of Cyclin D1 and suppression of Ki-67 and PCNA in RS-treated animals. We report the development of the first large animal model of sustained liver injury with suppression of hepatic regeneration.

Original languageEnglish
Article number14987
JournalScientific Reports
Volume8
Issue number1
DOIs
Publication statusPublished - 2018 Dec 1

Fingerprint

Liver Regeneration
Hepatectomy
Animal Models
Wounds and Injuries
Liver
Swine
Regenerative Medicine
retrorsine
Cyclin D1
Proliferating Cell Nuclear Antigen
Liver Diseases
Regeneration
Staining and Labeling
Serum

ASJC Scopus subject areas

  • General

Cite this

A Pre-Clinical Large Animal Model of Sustained Liver Injury and Regeneration Stimulus. / Inomata, Kenta; Tajima, Kazuki; Yagi, Hiroshi; Higashi, Hisanobu; Shimoda, Hirofumi; Matsubara, Kentaro; Hibi, Taizo; Abe, Yuta; Tsujikawa, Hanako; Kitago, Minoru; Shinoda, Masahiro; Obara, Hideaki; Itano, Osamu; Soto-Gutierrez, Alejandro; Kitagawa, Yuukou.

In: Scientific Reports, Vol. 8, No. 1, 14987, 01.12.2018.

Research output: Contribution to journalArticle

@article{f590192f4f014ee0a1cbf4cc881fafab,
title = "A Pre-Clinical Large Animal Model of Sustained Liver Injury and Regeneration Stimulus",
abstract = "A feasible large animal model to evaluate regenerative medicine techniques is vital for developing clinical applications. One such appropriate model could be to use retrorsine (RS) together with partial hepatectomy (PH). Here, we have developed the first porcine model using RS and PH. RS or saline control was administered intraperitoneally to G{\"o}ttingen miniature pigs twice, two weeks apart. Four weeks after the second dose, animals underwent PH. Initially, we tested different doses of RS and resection of different amounts of liver, and selected 50 mg/kg RS with 60{\%} hepatectomy as our model for further testing. Treated animals were sacrificed 3, 10, 17 or 28 days after PH. Blood samples and resected liver were collected. Serum and liver RS content was determined by Liquid Chromatograph-tandem Mass Spectrometer. Blood analyses demonstrated liver dysfunction after PH. Liver regeneration was significantly inhibited 10 and 17 days after PH in RS-treated animals, to the extent of 20{\%}. Histological examination indicated hepatic injury and regenerative responses after PH. Immunohistochemical staining demonstrated accumulation of Cyclin D1 and suppression of Ki-67 and PCNA in RS-treated animals. We report the development of the first large animal model of sustained liver injury with suppression of hepatic regeneration.",
author = "Kenta Inomata and Kazuki Tajima and Hiroshi Yagi and Hisanobu Higashi and Hirofumi Shimoda and Kentaro Matsubara and Taizo Hibi and Yuta Abe and Hanako Tsujikawa and Minoru Kitago and Masahiro Shinoda and Hideaki Obara and Osamu Itano and Alejandro Soto-Gutierrez and Yuukou Kitagawa",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-018-32889-y",
language = "English",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - A Pre-Clinical Large Animal Model of Sustained Liver Injury and Regeneration Stimulus

AU - Inomata, Kenta

AU - Tajima, Kazuki

AU - Yagi, Hiroshi

AU - Higashi, Hisanobu

AU - Shimoda, Hirofumi

AU - Matsubara, Kentaro

AU - Hibi, Taizo

AU - Abe, Yuta

AU - Tsujikawa, Hanako

AU - Kitago, Minoru

AU - Shinoda, Masahiro

AU - Obara, Hideaki

AU - Itano, Osamu

AU - Soto-Gutierrez, Alejandro

AU - Kitagawa, Yuukou

PY - 2018/12/1

Y1 - 2018/12/1

N2 - A feasible large animal model to evaluate regenerative medicine techniques is vital for developing clinical applications. One such appropriate model could be to use retrorsine (RS) together with partial hepatectomy (PH). Here, we have developed the first porcine model using RS and PH. RS or saline control was administered intraperitoneally to Göttingen miniature pigs twice, two weeks apart. Four weeks after the second dose, animals underwent PH. Initially, we tested different doses of RS and resection of different amounts of liver, and selected 50 mg/kg RS with 60% hepatectomy as our model for further testing. Treated animals were sacrificed 3, 10, 17 or 28 days after PH. Blood samples and resected liver were collected. Serum and liver RS content was determined by Liquid Chromatograph-tandem Mass Spectrometer. Blood analyses demonstrated liver dysfunction after PH. Liver regeneration was significantly inhibited 10 and 17 days after PH in RS-treated animals, to the extent of 20%. Histological examination indicated hepatic injury and regenerative responses after PH. Immunohistochemical staining demonstrated accumulation of Cyclin D1 and suppression of Ki-67 and PCNA in RS-treated animals. We report the development of the first large animal model of sustained liver injury with suppression of hepatic regeneration.

AB - A feasible large animal model to evaluate regenerative medicine techniques is vital for developing clinical applications. One such appropriate model could be to use retrorsine (RS) together with partial hepatectomy (PH). Here, we have developed the first porcine model using RS and PH. RS or saline control was administered intraperitoneally to Göttingen miniature pigs twice, two weeks apart. Four weeks after the second dose, animals underwent PH. Initially, we tested different doses of RS and resection of different amounts of liver, and selected 50 mg/kg RS with 60% hepatectomy as our model for further testing. Treated animals were sacrificed 3, 10, 17 or 28 days after PH. Blood samples and resected liver were collected. Serum and liver RS content was determined by Liquid Chromatograph-tandem Mass Spectrometer. Blood analyses demonstrated liver dysfunction after PH. Liver regeneration was significantly inhibited 10 and 17 days after PH in RS-treated animals, to the extent of 20%. Histological examination indicated hepatic injury and regenerative responses after PH. Immunohistochemical staining demonstrated accumulation of Cyclin D1 and suppression of Ki-67 and PCNA in RS-treated animals. We report the development of the first large animal model of sustained liver injury with suppression of hepatic regeneration.

UR - http://www.scopus.com/inward/record.url?scp=85054778548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054778548&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-32889-y

DO - 10.1038/s41598-018-32889-y

M3 - Article

C2 - 30301901

AN - SCOPUS:85054778548

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 14987

ER -